6-氨基青霉素酸相关物质的UPLC-Q-Exactive Orbitrap-MS/MS和NMR表征。

IF 3.1 3区 医学 Q2 CHEMISTRY, ANALYTICAL
Jiajie Wu , Jing Lu , Ju Liu , Huimin Yi , Ben Zhou , Hua Chang , Hongjuan Pan
{"title":"6-氨基青霉素酸相关物质的UPLC-Q-Exactive Orbitrap-MS/MS和NMR表征。","authors":"Jiajie Wu ,&nbsp;Jing Lu ,&nbsp;Ju Liu ,&nbsp;Huimin Yi ,&nbsp;Ben Zhou ,&nbsp;Hua Chang ,&nbsp;Hongjuan Pan","doi":"10.1016/j.jpba.2025.117143","DOIUrl":null,"url":null,"abstract":"<div><div>6-Aminopenicillanic acid (6-APA), a key intermediate in the synthesis of semi-synthetic penicillin antibiotics, was subjected to forced degradation under thermal, alkaline, acidic, oxidative, and photolytic conditions. The resulting degradation products were identified by ultra high-pressure liquid chromatography-quadrupole-Exactive Orbitrap mass/mass spectrometry (UPLC-Q-Exactive Orbitrap-MS/MS) and nuclear magnetic resonance (NMR) techniques. An oxidative forced degradation of 6-APA, designated RS7, was isolated and purified using semi-preparative liquid chromatography (semi-Prep-LC). Structural characterization confirmed RS7 as penicillamine disulfide. A total of 18 related substances were identified, comprising three process-related substances (including 2 pairs of isomers), and 14 degradation products (including 5 pairs of isomers). The degradation pathways of 6-APA were proposed and summarized. For the first time, the oxidative and reductive degradation products of 6-APA were identified, including the new detection of penicillamine disulfide among its forced degradation products.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"267 ","pages":"Article 117143"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characterization of related substances of 6-Aminopenicillanic acid using UPLC-Q-Exactive Orbitrap-MS/MS and NMR\",\"authors\":\"Jiajie Wu ,&nbsp;Jing Lu ,&nbsp;Ju Liu ,&nbsp;Huimin Yi ,&nbsp;Ben Zhou ,&nbsp;Hua Chang ,&nbsp;Hongjuan Pan\",\"doi\":\"10.1016/j.jpba.2025.117143\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>6-Aminopenicillanic acid (6-APA), a key intermediate in the synthesis of semi-synthetic penicillin antibiotics, was subjected to forced degradation under thermal, alkaline, acidic, oxidative, and photolytic conditions. The resulting degradation products were identified by ultra high-pressure liquid chromatography-quadrupole-Exactive Orbitrap mass/mass spectrometry (UPLC-Q-Exactive Orbitrap-MS/MS) and nuclear magnetic resonance (NMR) techniques. An oxidative forced degradation of 6-APA, designated RS7, was isolated and purified using semi-preparative liquid chromatography (semi-Prep-LC). Structural characterization confirmed RS7 as penicillamine disulfide. A total of 18 related substances were identified, comprising three process-related substances (including 2 pairs of isomers), and 14 degradation products (including 5 pairs of isomers). The degradation pathways of 6-APA were proposed and summarized. For the first time, the oxidative and reductive degradation products of 6-APA were identified, including the new detection of penicillamine disulfide among its forced degradation products.</div></div>\",\"PeriodicalId\":16685,\"journal\":{\"name\":\"Journal of pharmaceutical and biomedical analysis\",\"volume\":\"267 \",\"pages\":\"Article 117143\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmaceutical and biomedical analysis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0731708525004844\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525004844","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

摘要

6-氨基青霉素酸(6-APA)是合成半合成青霉素抗生素的关键中间体,在热、碱性、酸性、氧化和光解条件下被强制降解。通过超高压液相色谱-四极杆萃取轨道阱质谱(UPLC-Q-Exactive Orbitrap-MS/MS)和核磁共振(NMR)技术对降解产物进行鉴定。采用半制备液相色谱(semi- prepare - lc)分离纯化了一种氧化强制降解的6-APA,命名为RS7。结构表征证实RS7为二硫化青霉胺。共鉴定出18种相关物质,其中工艺相关物质3种(含2对异构体),降解产物14种(含5对异构体)。提出并总结了6-APA的降解途径。首次鉴定了6-APA的氧化和还原降解产物,包括在其强制降解产物中新检测到二硫化青霉胺。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Characterization of related substances of 6-Aminopenicillanic acid using UPLC-Q-Exactive Orbitrap-MS/MS and NMR
6-Aminopenicillanic acid (6-APA), a key intermediate in the synthesis of semi-synthetic penicillin antibiotics, was subjected to forced degradation under thermal, alkaline, acidic, oxidative, and photolytic conditions. The resulting degradation products were identified by ultra high-pressure liquid chromatography-quadrupole-Exactive Orbitrap mass/mass spectrometry (UPLC-Q-Exactive Orbitrap-MS/MS) and nuclear magnetic resonance (NMR) techniques. An oxidative forced degradation of 6-APA, designated RS7, was isolated and purified using semi-preparative liquid chromatography (semi-Prep-LC). Structural characterization confirmed RS7 as penicillamine disulfide. A total of 18 related substances were identified, comprising three process-related substances (including 2 pairs of isomers), and 14 degradation products (including 5 pairs of isomers). The degradation pathways of 6-APA were proposed and summarized. For the first time, the oxidative and reductive degradation products of 6-APA were identified, including the new detection of penicillamine disulfide among its forced degradation products.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.70
自引率
5.90%
发文量
588
审稿时长
37 days
期刊介绍: This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome. Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信